CIK 0001061983 · Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 943291317
- Phone
- (650) 624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 4 Planned sale EVP, Chief Commercial Officer sold 15,000 shares at $61.93 ($928,950)
- 4 Planned sale EVP, Chief Commercial Officer sold 886 shares at $62.10 ($55,021)
- 4 Grant or award Director acquired 197 shares (grant or award)
- 4 Grant or award Director acquired 98 shares (grant or award)
- 4 Grant or award Director acquired 98 shares (grant or award)
- 4 Grant or award Director acquired 197 shares (grant or award)
- 4 Grant or award Director acquired 334 shares (grant or award)
- 4 Grant or award Director acquired 197 shares (grant or award)
- 4 Planned sale EVP, Chief Commercial Officer sold 15,000 shares at $60.28 ($904,200)
- 4 Planned sale EVP, Chief Commercial Officer sold 1,798 shares at an average $62.62 ($112,585)
- 144 Insider Sale of Securities
- 4 Planned sale EVP, Chief Commercial Officer sold 1,809 shares at $62.44 ($112,954)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes President & CEO gave up 2,935 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Research & Development gave up 1,016 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Commercial Officer gave up 675 shares (to pay taxes)
Page 8 of 127 · 2,534 filings